Jie Jiang

16PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersTraditional Chinese medicine and treatmentsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 28, 2025
Adverse Event Management in Patients with Platinum-Resistant Ovarian Cancer Treated with Niraparib and Anlotinib: Updates from the Phase II, Multi-Center ANNIE Study.

Ting Deng, Lei Yan, Jing Li

|May 14, 2025
Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis.

Rui Sun, Ying Zhao, Yao Liu

|Jan 09, 2025
Long non-coding RNA LINC01224 plays an oncogenic role in endometrial cancer via miR-4673/TPX2 axis and activating Wnt/β-catenin signaling pathway.

Shuqing Lv, Xinlu Zhang, Fangfang Lang

|Aug 18, 2023
Progress of immunotherapies in gestational trophoblastic neoplasms.

Tong Wang, Wenxiu Guo, Xiaochen Ren

|Jun 02, 2023
Novel insights into tumorigenesis and prognosis of endometrial cancer through systematic investigation and validation on mitophagy-related signature.

Rui Sun, Xiaoyu Zhou, Tong Wang

|Mar 28, 2023
Anticancer Effect of Active Component of Astragalus Membranaceus Combined with Olaparib on Ovarian Cancer Predicted by Network-Based Pharmacology.

Yang Liu, Zhongkun Guo, Fangfang Lang

Pageof 3

Frequent Collaborators

5 joint publications

Xiaohong Ma

4 joint publications

Chunping Qiu

3 joint publications

Zhiming Liu

2 joint publications

Kui Guo